Holders

LIMINATUS PHARMA INC.

Q4 2025 13F holders

CUSIP
53271X116
Type
Equity
Class
*W EXP 04/30/203
Total Reported Value ($000, excl. options)
Manager Report date Value ($000) Shares Option type